Gamida Cell Ltd. (NASDAQ:GMDA) Q4 2023 Earnings Call Transcript

Vernon Bernardino: Thank you very much. That information is very helpful and looking forward to launch and best of luck.

Shai Lankry: Thank you.

Operator: Thank you. And I am showing no further questions in the queue. I’d like to turn it back to Abi Jenkins for closing remarks.

Abigail Jenkins: Thank you, Catherine. I want to reiterate that the changes we’ve announced today will make Gamida Cell a more focused, prioritized and attractive investment opportunity and create a path for near-term value creation with the potential approval and launch of Omidubicel. And to be clear, we do plan to launch immediately following approval is granted on May 1st. Our leadership team will be available after the call if there are any opportunities for follow-up discussions. We’ll keep you current on all of our developments, and we thank you again for your interest and support of Gamida Cell. Thank you, everyone, for joining us on today’s call.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.